key: cord-1036218-d54g98re
authors: Dubelbeiss, Emily; Silverberg, Michael; White, Chase; Jaspan, David; Haines, Christopher; Goldberg, Jay
title: Repeat positive SARS-CoV-2 (COVID-19) testing ≥ 90 days apart in pregnant women.
date: 2021-02-19
journal: Am J Obstet Gynecol MFM
DOI: 10.1016/j.ajogmf.2021.100331
sha: f2c541fb6014332aaa79623f76de1468579f44d1
doc_id: 1036218
cord_uid: d54g98re

nan

admission for delivery were symptomatic. 3 of the 45 (7%) women infected at delivery had prior SARS-CoV-2 tests that were positive  90 days (106, 116, and 151 days) previously. All three patients with repeat positive results were asymptomatic at the time of delivery, but two had upper respiratory infection symptoms at the time of their initial positive test. It is unknown why the asymptomatic patient was initially tested. None of the neonates of mothers with repeat COVID positive testing had any identifiable related adverse effects.

The 7% (3/45) of pregnant patients with repeat positive COVID-19 test results  90 days apart may have had reinfection, infection with a different viral strain or persistent infection. As viral genotyping, which is rarely done in the clinical setting, was not performed, it cannot be determined if different strains were present, however, this has not been reported in our area.

Persistent infection is unlikely as the median duration of viral RNA shedding has been reported to be 18 days. 3 False positive SARS-CoV-2 testing in all three patients is also unlikely given the manufacturer's reported negligible rate. 4 Additionally, the sensitivity and specificity of the test used were reported as 93% and 100%, respectively. 5 Thus, these three patients were most likely reinfected with COVID-19. The CDC has recommended that testing inside of 90 days for an asymptomatic patient not occur. Therefore, an asymptomatic patient who tests positive again after 90 days is treated as a new infection despite the fact that we are unable to provide factual evidence. 2 From an obstetrical point of view this impacts workflow regarding appropriate utilization of PPE, support person restrictions, and pediatric care. 6 Prior COVID-19 infection in pregnant women may not provide immunity to future infection. This may have larger implications as vaccination against SARS-CoV-2 is implemented. Further analysis with a larger number of patients, as well as genotyping on repeat positive test samples, would better define the true incidence of COVID-19 reinfection in pregnancy.

COVID-19 as the leading cause of death in the United States

Investigative Criteria for Suspected Cases of SARS-CoV-2 Reinfection (ICR)

Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature

Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance

Perceptions of patients and providers regarding restriction of labor and delivery support people in the early stages of the COVID-19 pandemic